# Adaptive Biotechnologies Corporation (ADPT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ADPT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 142.43M | $ -59.82M | $ -17.92M | $ 410.50M | $ 142.91M |
| 2025 | $ 283.60M | $ -60.92M | $ -50.12M | $ 280.58M | $ 218.79M |
| 2024 | $ 188.10M | $ -167.64M | $ -103.93M | $ 89.39M | $ 202.71M |
| 2023 | $ 184.11M | $ -243.55M | $ -180.59M | $ 98.77M | $ 308.40M |
| 2022 | $ 207.01M | $ -223.70M | $ -223.75M | $ 108.00M | $ 464.17M |
| 2021 | $ 183.46M | $ -246.27M | $ -302.48M | $ 111.74M | $ 603.99M |
| 2020 | $ 125.33M | $ -186.28M | $ -214.64M | $ 107.86M | $ 743.27M |
| 2019 | $ 109.81M | $ -88.55M | $ 250.67M | $ 36.61M | $ 571.04M |
| 2018 | $ 73.51M | $ -61.34M | $ -50.95M | $ 0 | $ -258.11M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.87 |
| Liabilities / Eq | 3.43 |
| Current Ratio | 4.79 |

## Other views

- [Metrics](https://sponda.capital/en/ADPT.md)
- [Charts](https://sponda.capital/en/ADPT/charts.md)
- [Compare](https://sponda.capital/en/ADPT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.